Cargando…
Deleted in liver cancer-1 inhibits cell growth and tumorigenicity in human pancreatic cancer
Deleted in liver cancer-1 (DLC-1) has been isolated from primary hepatocellular carcinoma and demonstrated to be a potential tumor suppressor gene. The aim of the present study was to observe the effect of the DLC-1 gene on pancreatic cancer cell growth and evaluate the feasibility of using the DLC-...
Autores principales: | ZHENG, ZHENJIANG, TAN, CHUNLU, XIANG, GUANGMING, MAI, GANG, LIU, XUBAO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789078/ https://www.ncbi.nlm.nih.gov/pubmed/24137359 http://dx.doi.org/10.3892/ol.2013.1415 |
Ejemplares similares
-
Risk of pancreatic cancer in patients undergoing surgery for chronic pancreatitis
por: Zheng, Zhenjiang, et al.
Publicado: (2019) -
Prevention and Treatment of Grade C Postoperative Pancreatic Fistula
por: Xiang, Chengzhi, et al.
Publicado: (2022) -
Disparities in survival by stage after surgery between pancreatic head and body/tail in patients with nonmetastatic pancreatic cancer
por: Zheng, Zhenjiang, et al.
Publicado: (2019) -
Elevated Bile Acid Is Associated with Worsened Impaired Glucose Homeostasis in Pancreatic Ductal Adenocarcinoma Patients with Extrahepatic Cholestasis through Increased Hepatic Insulin Clearance
por: Yang, Jie, et al.
Publicado: (2023) -
Association Between the Neutrophil-To-Lymphocyte Ratio and Diabetes Secondary to Exocrine Pancreatic Disorders
por: Chen, Guanhua, et al.
Publicado: (2022)